Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13045-017-0477-0
Published Online: 2017-05-16
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Lee, Ji Won
Lee, Sanghoon
Cho, Hee Won
Ma, Youngeun
Yoo, Keon Hee
Sung, Ki Woong
Koo, Hong Hoe
Cho, Eun Joo
Lee, Suk-Koo
Lim, Do Hoon
Funding for this research was provided by:
National R & D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (No. 1520210)